Literature DB >> 25630493

Visit-to-visit blood pressure variability: more to come.

Eleni Gavriilaki1, Eugenia Gkaliagkousi, Stella Douma.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25630493      PMCID： PMC8031736          DOI： 10.1111/jch.12480

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  16 in total

Review 1.  Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis.

Authors:  Keith M Diaz; Rikki M Tanner; Louise Falzon; Emily B Levitan; Kristi Reynolds; Daichi Shimbo; Paul Muntner
Journal:  Hypertension       Date:  2014-07-28       Impact factor: 10.190

Review 2.  Cardiovascular risk stratification and blood pressure variability on ambulatory and home blood pressure measurement.

Authors:  José Boggia; Kei Asayama; Yan Li; Tine Willum Hansen; Luis Mena; Rudolph Schutte
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

3.  Visit-to-visit blood pressure variability as a prognostic marker in patients with cardiovascular and cerebrovascular diseases--relationships and comparisons with vascular markers of atherosclerosis.

Authors:  Kui Kai Lau; Yuen Kwun Wong; Yap Hang Chan; Kay Cheong Teo; Koon Ho Chan; Leonard Sheung Wai Li; Raymond Tak Fai Cheung; Chung Wah Siu; Shu Leong Ho; Hung Fat Tse
Journal:  Atherosclerosis       Date:  2014-05-09       Impact factor: 5.162

4.  Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis.

Authors:  Giuseppe Mancia; Rita Facchetti; Gianfranco Parati; Alberto Zanchetti
Journal:  Circulation       Date:  2012-07-03       Impact factor: 29.690

5.  Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment.

Authors:  Giuseppe Mancia; Rita Facchetti; Gianfranco Parati; Alberto Zanchetti
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

6.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

7.  Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

Authors:  Peter M Rothwell; Sally C Howard; Eamon Dolan; Eoin O'Brien; Joanna E Dobson; Bjorn Dahlöf; Peter S Sever; Neil R Poulter
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

8.  Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77,299 patients.

Authors:  Chenhui Tai; Yuxi Sun; Neng Dai; Dachun Xu; Wei Chen; Jiguang Wang; Athanase Protogerou; Thomas T van Sloten; Jacques Blacher; Michel E Safar; Yi Zhang; Yawei Xu
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-03       Impact factor: 3.738

9.  Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting.

Authors:  Amanda D Hyre; Marie A Krousel-Wood; Paul Muntner; Lumie Kawasaki; Karen B DeSalvo
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-03       Impact factor: 3.738

10.  Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Authors:  Paul Muntner; Emily B Levitan; Amy I Lynch; Lara M Simpson; Jeffrey Whittle; Barry R Davis; John B Kostis; Paul K Whelton; Suzanne Oparil
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-04-16       Impact factor: 3.738
View more
  1 in total

1.  Incidence of atrial fibrillation and its risk prediction model based on a prospective urban Han Chinese cohort.

Authors:  L Ding; J Li; C Wang; X Li; Q Su; G Zhang; F Xue
Journal:  J Hum Hypertens       Date:  2017-03-30       Impact factor: 3.012
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.